Delivery Order SPE2DE24D0013-SPE2D626F11C9

Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, received a delivery order valued at $9,104.20 from the Defense Logistics Agency Medical Supply Chain on December 11, 2025, for COVID-19, influenza, and respiratory syncytial virus diagnostic products. The contract, designated XPCOV2/FLU/RSV-10, is structured as a firm fixed-price delivery order with an ultimate completion date of December 18, 2025, and carries no set-aside designation. This award represents continued federal procurement of Cepheid's GeneXpert diagnostic platform reagents and test kits, which the company has supplied extensively across multiple federal healthcare agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard.

This delivery order falls under the Defense Logistics Agency's medical supply chain operations and reflects Cepheid's established role as a primary federal supplier of rapid molecular diagnostic testing solutions. The company maintains two significant Indefinite Delivery Contracts with the Department of Veterans Affairs—including a $32.8 million contract with VISN 6 extending through September 2030 and a $6.7 million contract with VISN 17 through December 2029—which serve as the framework for ongoing procurement of diagnostic reagents and test kits across the VA's distributed network of medical centers. Cepheid's federal portfolio demonstrates substantial capability in delivering molecular diagnostic equipment, reagents, and maintenance services to support infectious disease detection across the federal healthcare system.